TBOPP, a DOCK1 Inhibitor, Potentiates Cisplatin Efficacy in Breast Cancer by Regulating Twist-mediated EMT.
Chen X, Zhou Z, Tang P, Du F, Wang S, Yao J, Zhang S, Huang J, Lu X, Chen W, Yu X, Liu Y, Liu H.
Chen X, et al. Among authors: chen w.
Curr Cancer Drug Targets. 2024 Feb 26. doi: 10.2174/0115680096281231240202073558. Online ahead of print.
Curr Cancer Drug Targets. 2024.
PMID: 38415469